Two-Site Occupation for Constructing Double Perovskite BaLaMgNbO6:Cr3+ Ultrabroadband NIR Phosphors.

Given the escalating significance of near-infrared (NIR) spectroscopy across industries, agriculture, and various domains, there is an imminent need to address the development of a novel generation of intelligent NIR light sources. Here, a series of Cr3+-doped BaLaMgNbO6 (BLMN) ultrabroadband NIR phosphor with a coverage range of 650-1300 nm were developed. The emission peak locates at 830 nm with a full width at half maximum of 210 nm. This ultrabroadband emission originates from the 4T2→4A2 transition of Cr3+ and the simultaneous occupation of [MgO6] and [NbO6] octahedral sites confirmed by low photoluminescence spectra (77-250 K), time-resolved photoluminescence spectra, and electron paramagnetic resonance spectra. The fluxing strategy improves the luminescence intensity and thermal stability of BLMN:0.02Cr3+ phosphors. The internal quantum efficiency (IQE) is 51%, external quantum efficiency (EQE) can reach 33%, and thermal stability can be maintained at 60%@100 °C. Finally, we successfully demonstrated the application of BLMN:Cr3+ ultrabroadband in the qualitative analysis of organic matter and food freshness detection.

Hydralazine loaded nanodroplets combined with ultrasound-targeted microbubble destruction to induce pyroptosis for tumor treatment.

Pyroptosis, a novel type of programmed cell death (PCD), which provides a feasible therapeutic option for the treatment of tumors. However, due to the hypermethylation of the promoter, the critical protein Gasdermin E (GSDME) is lacking in the majority of cancer cells, which cannot start the pyroptosis process and leads to dissatisfactory therapeutic effects. Additionally, the quick clearance, systemic side effects, and low concentration at the tumor site of conventional pyroptosis reagents restrict their use in clinical cancer therapy. Here, we described a combination therapy that induces tumor cell pyroptosis via the use of ultrasound-targeted microbubble destruction (UTMD) in combination with DNA demethylation. The combined application of UTMD and hydralazine-loaded nanodroplets (HYD-NDs) can lead to the rapid release of HYD (a demethylation drug), which can cause the up-regulation of GSDME expression, and produce reactive oxygen species (ROS) by UTMD to cleave up-regulated GSDME, thereby inducing pyroptosis. HYD-NDs combined with ultrasound (US) group had the strongest tumor inhibition effect, and the tumor inhibition rate was 87.15% (HYD-NDs group: 51.41 ± 3.61%, NDs + US group: 32.73%±7.72%), indicating that the strategy had a more significant synergistic anti-tumor effect. In addition, as a new drug delivery carrier, HYD-NDs have great biosafety, tumor targeting, and ultrasound imaging performance. According to the results, the combined therapy reasonably regulated the process of tumor cell pyroptosis, which offered a new strategy for optimizing the therapy of GSDME-silenced solid tumors.

Multiwavelength Excitation in Ho3+-Doped All-Inorganic Double Perovskites Achieved by Codoping Mn2+ for Warm-White LEDs and Plant Growth.

Doping lanthanide ions is an efficient method to modify the optical properties of lead-free double-perovskite halides. However, most lanthanide-doped double perovskites show a low luminescence efficiency and require a high excitation energy. Here, we have successfully prepared a series of Ho3+-doped Cs2NaBiCl6 microcrystals through a simple hydrothermal method and obtained strong characteristic emissions of Ho3+ at 492 and 657 nm under low-energy excitation (449 nm). After codoping Mn2+, apart from the characteristic emissions from Ho3+ under 450 nm wavelength excitation, the orangish-red luminescence consisting of the emission band centered at 591 nm from Mn2+ and a sharp emission peak at 657 nm from Ho3+ is obtained under 355 nm UV light excitation. Photoluminescence (PL) emission and excitation spectra, along with the PL decay curves, confirm the existence of an energy-transfer channel from Cs2NaBiCl6 to Mn2+ and then from Mn2+ to Ho3+. The enhanced absorption efficiency (10.5 → 70.7%) suggests that the codoping of Mn2+ overcomes the low absorption efficiency caused by f-f forbidden transitions of Ho3+. Finally, the diverse luminescent performance within the Cs2NaBiCl6:Ho3+, Mn2+ phosphor is realized by altering the excitation wavelength, thereby enabling its application in warm-white-light-emitting diodes and plant growth in this work.

Thermally Stable Red-Emitting Ca18K3Sc(PO4)14:Mn2+ Phosphor and Enhanced Luminescence by Energy Transfer Between Ce3+-Eu2+-Mn2.

It is significant and valuable to investigate novel and high-performance red-emitting phosphors for high-quality wLED applications. Based on this consideration, we developed a novel Mn2+-doped red Ca18K3Sc(PO4)14:Mn2+ (CKSP:Mn2+) phosphor. The emission peak of CKSP:Mn2+ is located at 640 nm, presenting a broadband red emission with a fwhm of 79 nm under 405 nm excitation. The CKSP:1.0Mn2+ phosphor shows superior thermal stability. At 150 °C, the integrated PL intensity and peak intensity of the CKSP:1.0Mn2+ phosphor maintain 93.2 and 85.7% of those at 25 °C, respectively. Through the strategy of energy transfer among Ce3+-Eu2+-Mn2+, the PL intensity of Mn2+ has increased by nearly 118 times, and the quantum yield has improved from 6 up to 72%. The structure-related photoluminescence and energy transfer mechanisms are discussed in detail. The as-fabricated wLED pumped by a 370 nm LED chip combining commercial the green (Sr,Ba)2SiO4:Eu2+ phosphor, blue BaMgAl10O17:Eu2+ phosphor, and the as-synthesized CKSP:1.0Mn2+, 0.02Eu2+, 0.40Ce3+ phosphor shows excellent color quality (CCT = 5555 K, Ra = 87), which indicates that the CKSP:1.0Mn2+, 0.02Eu2+, 0.40Ce3+ phosphor has extraordinary broad prospects in future wLED applications.

A combination of PD-L1-targeted IL-15 mRNA nanotherapy and ultrasound-targeted microbubble destruction for tumor immunotherapy.

PD-1/PD-L1-based immune checkpoint blockade therapy has shown limited benefits in tumor patients, partially attributed to the inadequate infiltration of immune effector cells within tumors. Here, we established a nanoplatform named DPPA/IL-15 NPs to target PD-L1 for the tumor delivery of IL-15 messenger RNA (mRNA). DPPA/IL-15 NPs were endowed with ultrasound responsiveness and contrast-enhanced ultrasound (CEUS) imaging performance. They effectively protected IL-15 mRNA from degradation and specifically transfected it into tumor cells through the utilization of ultrasound-targeted microbubble destruction (UTMD). This resulted in the activation of IL-15-related immune effector cells while blocking the PD-1/PD-L1 pathway. In addition, UTMD could generate reactive oxygen species (ROS) that induce endoplasmic reticulum (ER) stress-driven immunogenic cell death (ICD), initiating anti-tumor immunity. In vitro and in vivo studies revealed that this combination therapy could induce a robust systemic immune response and enhance anti-tumor efficacy. Thus, this combination therapy has the potential for clinical translation through enhanced immunotherapy and provides real-time ultrasound imaging guidance.

Valence conversion and site reconstruction in near-infrared-emitting chromium-activated garnet for simultaneous enhancement of quantum efficiency and thermal stability.

Achievement of high photoluminescence quantum efficiency and thermal stability is challenging for near-infrared (NIR)-emitting phosphors. Here, we designed a "kill two birds with one stone" strategy to simultaneously improve quantum efficiency and thermal stability of the NIR-emitting Ca3Y2-2x(ZnZr)xGe3O12:Cr garnet system by chemical unit cosubstitution, and revealed universal structure-property relationship and the luminescence optimization mechanism. The cosubstitution of [Zn2+-Zr4+] for [Y3+-Y3+] played a critical role as reductant to promote the valence transformation from Cr4+ to Cr3+, resulting from the reconstruction of octahedral sites for Cr3+. The introduction of [Zn2+-Zr4+] unit also contributed to a rigid crystal structure. These two aspects together realized the high internal quantum efficiency of 96% and excellent thermal stability of 89%@423 K. Moreover, information encryption with "burning after reading" was achieved based on different chemical resistance of the phosphors to acid. The developed NIR-emitting phosphor-converted light-emitting diode demonstrated promising applications in bio-tissue imaging and night vision. This work provides a new perspective for developing high-performance NIR-emitting phosphor materials.

CAFs targeted ultrasound-responsive nanodroplets loaded V9302 and GLULsiRNA to inhibit melanoma growth via glutamine metabolic reprogramming and tumor microenvironment remodeling.

Despite rapid advances in metabolic therapies over the past decade, their efficacy in melanoma has been modest, largely due to the interaction between cancer-associated fibroblasts (CAFs) and cancer cells to promote cancer growth. Altering the tumor microenvironment (TME) is challenging and elusive. CAFs is critical for glutamine deprivation survival in melanoma. In this research, we assembled a CAFs-targeted, controlled-release nanodroplets for the combined delivery of the amino acid transporter ASCT2 (SLC1A5) inhibitor V9302 and GLULsiRNA (siGLUL). The application of ultrasound-targeted microbubble disruption (UTMD) allows for rapid release of V9302 and siGLUL, jointly breaking the glutamine metabolism interaction between CAFs and cancer cells on one hand, on the other hand, blocking activated CAFs and reducing the expression of extracellular matrix (ECM) to facilitate drug penetration. In addition, ultrasound stimulation made siGLUL more accessible to tumor cells and CAFs, downregulating GLUL expression in both cell types. FH-V9302-siGLUL-NDs also serve as contrast-enhanced ultrasound imaging agents for tumor imaging. Our study developed and reported FH-NDs as nanocarriers for V9302 and siGLUL, demonstrating that FH-V9302-siGLUL-NDs have potential bright future applications for integrated diagnostic therapy. Graphical Abstract.

Full-surface defect detection of navel orange based on hyperspectral online sorting technology.

The whole-surface hyperspectral image acquisition of navel orange is particularly important for surface defect detection and quality classification. Because the light intensity at the edge of the navel orange is lower than that in the middle, the defects on the surface of the navel orange cannot be effectively identified. In this paper, a hyperspectral online sorting device for the whole-surface defects of navel orange is proposed. First of all, the image data of navel orange is collected by online detection sorting equipment and the spectral image of the characteristic wave peak of 1655.72 nm was extracted. Then, the light intensity at the edge of the navel orange is enhanced by nonuniformity correction based on quadratic curve fitting, and the light intensity correction of the navel orange is realized. Finally, the corrected image is segmented by the threshold to obtain surface defects, and the number of surface defect pixels is improved effectively compared with that before light intensity correction. Ultimately, the online sorting test is carried out, and the detection accuracy is 100%. This indicates that this method effectively improves the sensitivity of defect detection. At the same time, the dimensionality reduction of hyperspectral data is also carried out, which is conducive to improving the efficiency of online detection.

Ultrasound-Targeted Microbubble Disruption with Key Nanodroplets for Effective Ferroptosis in Triple-Negative Breast Cancer Using Animal Model.

Introduction: Triple-negative breast cancer (TNBC) is known to be the most aggressive form of breast cancer. Due to its high recurrence and mortality rates, the treatment of TNBC is a significant challenge for the medical community. Besides, ferroptosis is an emerging regulatory cell death that may provide new insights into the treatment of TNBC. As a central inhibitor of the ferroptosis process, the selenoenzyme glutathione peroxidase 4 (GPX4) is its classical therapeutic target. However, inhibition of GPX4 expression is quite detrimental to normal tissues. Ultrasound contrast agents, as an emerging visualization precision treatment, may provide a solution to the existing problem. Methods: In this study, nanodroplets (NDs) carrying simvastatin (SIM) were constructed using the homogeneous/emulsification method. Then, the characterization of SIM-NDs was systematically evaluated. Meanwhile, in this study, the ability of SIM-NDs combined with ultrasound-targeted microbubble disruption (UTMD) to initiate ferroptosis and its respective mechanisms of ferroptosis induction were verified. Finally, the antitumor activity of SIM-NDs was investigated in vitro and in vivo using MDA-MB-231 cells and TNBC animal models. Results: SIM-NDs exhibited excellent pH- and ultrasound-responsive drug release and noticeable ultrasonographic imaging ability, also showing good biocompatibility and biosafety. UTMD could promote increased intracellular reactive oxygen species and consume intracellular glutathione. However, SIM-NDs were efficiently internalized into cells under ultrasound irradiation, followed by the rapid release of SIM, which inhibited intracellular mevalonate production, and synergistically downregulated GPX4 expression, thereby promoting ferroptosis. Moreover, this combined treatment demonstrated strong antitumor ability in vitro and in vivo. Conclusion: The combination of UTMD and SIM-NDs presents a promising avenue for harnessing ferroptosis in the treatment of malignant tumors.

pH-/Redox-Responsive Nanodroplet Combined with Ultrasound-Targeted Microbubble Destruction for the Targeted Treatment of Drug-Resistant Triple Negative Breast Cancer.

Multiple drug resistance (MDR) exists in divergent cancers including triple negative breast cancer (TNBC) and partly results in the resistance to many first-line anti-cancer agents, bringing a big challenge to TNBC management. To develop novel TNBC therapeutics, in our study, a hyaluronic acid (HA)-carboxymethyl chitosan (CMC) conjugate linked via a disulfide-bond (HA-SS-CMC, HSC) was synthesized to fabricate nanodroplets (NDs). The NDs encapsulating doxorubicin (DOX) and perfluorohexane (DOX-HSC-NDs) were prepared via a homogenization/emulsification strategy and exhibited not only high biocompatibility but also noticeable tumor cell targeting ability and dual pH/redox responsiveness. Besides, DOX-HSC-NDs can be used as a contrast-enhanced ultrasound imaging agent for specific tumor imaging. DOX-HSC-NDs in combination with ultrasound targeted microbubble destruction could improve intracellular drug aggregation and retention of MDR cells and work against multiple mechanisms of drug resistance through synergistic strategies, including up-regulating the reactive oxygen species (ROS) level, promoting apoptosis, and scavenging glutathione, while reducing the expression levels of P-glycoprotein and inhibiting the epithelial-mesenchymal transition. This combination strategy showed protective effects against TNBC in both MDA-MB-231/ADR cells and tumor-bearing mice. Our study for the first time developed and reported the ultrasound-augmented HSC-NDs as the DOX nanocarrier and provided scientific evidence to support the future application of DOX-HSC-NDs as a potential TNBC therapy.

Ultrasound targeted microbubble destruction-triggered nitric oxide release via nanoscale ultrasound contrast agent for sensitizing chemoimmunotherapy.

Immunotherapy had demonstrated inspiring effects in tumor treatment, but only a minority of people could benefit owing to the hypoxic and immune-suppressed tumor microenvironment (TME). Therefore, there was an urgent need for a strategy that could relieve hypoxia and increase infiltration of tumor lymphocytes simultaneously. In this study, a novel acidity-responsive nanoscale ultrasound contrast agent (L-Arg@PTX nanodroplets) was constructed to co-deliver paclitaxel (PTX) and L-arginine (L-Arg) using the homogenization/emulsification method. The L-Arg@PTX nanodroplets with uniform size of about 300 nm and high drug loading efficiency displayed good ultrasound diagnostic imaging capability, improved tumor aggregation and achieved ultrasound-triggered drug release, which could prevent the premature leakage of drugs and thus improve biosafety. More critically, L-Arg@PTX nanodroplets in combination with ultrasound targeted microbubble destruction (UTMD) could increase cellular reactive oxygen species (ROS), which exerted an oxidizing effect that converted L-Arg into nitric oxide (NO), thus alleviating hypoxia, sensitizing chemotherapy and increasing the CD8 + cytotoxic T lymphocytes (CTLs) infiltration. Combined with the chemotherapeutic drug PTX-induced immunogenic cell death (ICD), this promising strategy could enhance immunotherapy synergistically and realize powerful tumor treatment effect. Taken together, L-Arg@PTX nanodroplets was a very hopeful vehicle that integrated drug delivery, diagnostic imaging, and chemoimmunotherapy.

A high-fiber diet synergizes with Prevotella copri and exacerbates rheumatoid arthritis.

Both preclinical and established rheumatoid arthritis (RA) patients display alterations in the gut microbiome. Prevotella spp. are preferentially enriched in a subset of RA patients. Here, we isolated a Prevotella strain, P. copri RA, from the feces of RA patients and showed that colonization of P. copri RA exacerbated arthritis in a collagen-induced arthritis (CIA) model. With the presence of P. copri RA colonization, a high-fiber diet exacerbated arthritis via microbial alterations and intestinal inflammation. Colonization of P. copri together with a high-fiber diet enabled the digestion of complex fiber, which led to the overproduction of organic acids, including fumarate, succinate and short-chain fatty acids. Succinate promoted proinflammatory responses in macrophages, and supplementation with succinate exacerbated arthritis in the CIA model. Our findings highlight the importance of dysbiosis when evaluating the effects of dietary interventions on RA pathogenesis and provide new insight into dietary interventions or microbiome modifications to improve RA management.

Highly efficient Fe3+-doped A2BB'O6 (A = Sr2+, Ca2+; B, B' = In3+, Sb5+, Sn4+) broadband near-infrared-emitting phosphors for spectroscopic analysis.

Near-infrared (NIR)-emitting phosphor-converted light-emitting diodes have attracted widespread attention in various applications based on NIR spectroscopy. Except for typical Cr3+-activated NIR-emitting phosphors, next-generation Cr3+-free NIR-emitting phosphors with high efficiency and tunable optical properties are highly desired to enrich the types of NIR luminescent materials for different application fields. Here, we report the Fe3+-activated Sr2-yCay(InSb)1-zSn2zO6 phosphors that exhibit unprecedented long-wavelength NIR emission. The overall emission tuning from 885 to 1005 nm with broadened full-width at half maximum from 108 to 146 nm was realized through a crystallographic site engineering strategy. The NIR emission was significantly enhanced after complete Ca2+ incorporation owing to the substitution-induced lower symmetry of the Fe3+ sites. The Ca2InSbO6:Fe3+ phosphor peaking at 935 nm showed an ultra-high internal quantum efficiency of 87%. The as-synthesized emission-tunable phosphors demonstrated great potential for NIR spectroscopy detection. This work initiates the development of efficient Fe3+-activated broadband NIR-emitting phosphors and opens up a new avenue for designing NIR-emitting phosphor materials.

Photoluminescence Properties of AScSi2O6:Cr3+ (A = Na and Li) Phosphors with High Efficiency and Thermal Stability for Near-Infrared Phosphor-Converted Light-Emitting Diode Light Sources.

Near-infrared (NIR) phosphors are fascinating photoluminescence materials with applications in phosphor-converted light-emitting diodes (pc-LEDs) for night vision lighting, which are still restricted by low efficiency and thermal stability in the current research stage. In this work, AScSi2O6 (A = Na/Li) are chosen as hosts due to a larger band gap and a single octahedral site for Cr3+ doping. The NIR-emitting Cr3+-activated AScSi2O6:Cr3+ phosphors were successfully prepared by a common high-temperature solid-state method. X-ray diffraction and Rietveld refinement confirm that the Cr3+ prefers to enter the Sc3+-octahedral lattice site in the AScSi2O6 structure. Under blue light excitation, AScSi2O6:Cr3+ phosphors exhibit broadband NIR emission from 700 to 1100 nm with a full width at half-maximum of ∼150 nm owing to the 4T2 → 4A2 electron transition of Cr3+. The photoluminescence properties were enhanced by adjusting the fluxes and sintering conditions, and highly efficient LiScSi2O6:Cr3+ NIR phosphors with external quantum efficiencies of 33.4% were obtained. Moreover, the optimized LiScSi2O6:Cr3+ exhibits excellent thermal stability (75% at 150 °C) with an activation energy of 0.33 eV. Importantly, the fabricated NIR pc-LED with the highly efficient LiScSi2O6:Cr3+ phosphor demonstrates brighter NIR light and a higher luminous efficacy than the NaScSi2O6:Cr3+ phosphor in night vision.

Utilizing RNA nanotechnology to construct negatively charged and ultrasound-responsive nanodroplets for targeted delivery of siRNA.

Ultrasound nanodroplets (NDs) have been reported as a promising nanocarrier for siRNA delivery depending on its unique strengths of sonoporation. Presently, common means for NDs-mediated siRNA delivery is through electrostatic interaction, but challenges like cationic toxicity still exist. In this study, we demonstrated a novel strategy to construct negatively charged and ultrasound (US)-responsive O-carboxymethyl chitosan (O-CMS) NDs as a siRNA targeted delivery system through three-way junction of bacteriophage phi29 DNA packaging motor (3WJ-pRNA) nanotechnology. 39nt A10-3.2 aptamer targeting prostate specific membrane antigen (PSMA) and 21nt siRNA against cationic amino acid transporter 1 (siCAT-1) were annealed to 3WJ-pRNA scaffold via complementation with an extended sequence. The cholesterol molecule attached to one branch facilitates the 3WJ-pRNA nanoparticles anchoring onto NDs. The desired O-CMS NDs with siRNA-loading and RNA-aptamer modification (A10-3.2/siCAT-1/3WJ-NDs) were successfully prepared, which were with spherical shapes, core-shell structures and uniform in sizes (198 nm with PDI 0.3). As a main proportion of shell, O-CMC showed a certain anti-tumor effects. In vitro studies demonstrated that A10-3.2/siCAT-1/3WJ-NDs exhibited good contrast-enhanced US imaging, buffering capacity and high bio-safety, were able to deliver siCAT-1 to PSMA-overexpressed prostate cancer cells under US irradiation, thus silence the CAT-1 expression, and consequently suppressing 22RV1 cell proliferation and migration. Taken overall, our findings provide a promising strategy to develop negatively charged and US-responsive NDs for tumor-targeted siRNA delivery.

Dual-responsive nanodroplets combined with ultrasound-targeted microbubble destruction suppress tumor growth and metastasis via autophagy blockade.

The inhibition of autophagy is a feasible clinical strategy in tumor therapy. Traditional autophagy inhibitors are limited in clinical tumor therapy due to nonspecific biodistribution, systemic toxicity and limited antitumor effect. Herein, the autophagy inhibitor hydroxychloroquine (HCQ)-loaded nanodroplets (NDs) are synthesized to overcome these drawbacks. HCQ-NDs are endowed with endogenous pH- and exogenous ultrasound-responsive drug release and contrast enhanced ultrasound imaging performance. The combined application of ultrasound-targeted microbubble destruction (UTMD) and HCQ-NDs can severely break the homeostasis of tumor cells, simultaneously releasing HCQ rapidly to block autophagic flux and thus abolish the cytoprotective function. This strategy presents strong synergistic antitumor efficacy with the tumor growth inhibition value of 80.02% and synchronously inhibits tumor lung metastasis by inhibition of MMP2 and MMP9 production, eventually leading to tumor suppression. In addition, HCQ-NDs show excellent tumor-targeting, biocompatibility, biosafety and contrast-enhanced ultrasound imaging properties. Based on the above findings, this combined strategy rationally regulates the autophagic process of tumor cells and could be instructive for the design of clinical treatment modalities.

GRP78-targeted and doxorubicin-loaded nanodroplets combined with ultrasound: a potential novel theranostics for castration-resistant prostate cancer.

The construction of multifunctional oncotherapy nanoplatforms that combine diagnosis and treatment remains challenging. Nanodroplets (NDs), which simultaneously enhance ultrasound imaging and therapeutic effects, are a potential strategy for non-invasive drug delivery. To achieve the goals of precise medicine, novel SP94 peptide-modified and doxorubicin-loaded ultrasonic NDs (SP94-DOX-NDs) for castration-resistant prostate cancer (CRPC) targeting and treatment were constructed in this study. The characteristics, contrast-enhanced ultrasound imaging (CEUI), targeting ability to glucose-regulated protein 78 (GRP78)-overexpressing CRPC and anticancer effect of the SP94-DOX-NDs were assessed. The desired SP94-NDs were successfully prepared using the nanoemulsification method using a certain proportion of SP94-PEG-chitosan, perfluoropentane (PFP), Tween 20, and lecithin. SP94-NDs with a size of ∼300 nm showed great biocompatibility and CEUI ability. Compared with blank NDs, SP94-NDs exhibited higher tumor-specific targeting ability due to conjugation between the SP94 peptide and GRP78-overexpressing 22RV1 cells. Most importantly, in vitro and in vivo investigations showed that SP94-DOX-NDs combined with ultrasound could specifically deliver DOX into 22RV1 cells and thereby demonstrated a stronger anticancer effect than DOX-NDs and DOX. Thus, SP94-DOX-NDs may provide an efficient approach for the real-time imaging of tumors and triggered, accurate drug delivery to tumors.

Regulation of Local Site Structures to Stabilize Mixed-Valence Eu2+/3+ under a Reducing Atmosphere for Multicolor Photoluminescence.

Co-doping mixed-valence Eu2+/3+ in a single-phase phosphor is an efficient method to realize the emission color regulation, which holds great potential for anticounterfeiting and ratiometric temperature sensing. Here, the mixed-valence Eu-doped Sr1.95+xLi1-xSi1-xAlxO4F (0 ≤ x ≤ 0.25) phosphors were designed and prepared under a reducing atmosphere. The correlation of local phase structures and luminescence properties was discussed. Replacing Si4+-Li+ ion pairs with Al3+-Sr2+ ion pairs compresses the Sr sites occupied by Eu2+, and it stabilizes Eu3+ in a reducing atmosphere and leads to the coexistence of Eu2+ and Eu3+ in single-phase Sr1.95+xLi1-xSi1-xAlxO4F:0.05Eu (0 ≤ x ≤ 0.25) phosphors. Based on the wavelength-dependent luminescence color behaviors of Sr1.95+xLi1-xSi1-xAlxO4F:0.05Eu phosphors, the fluorescent anticounterfeit papers/patterns containing Sr1.95+xLi1-xSi1-xAlxO4F:0.05Eu phosphors were the same as ordinary paper under ambient conditions. However, the hidden colors or images can be read out with green-orange luminescence under 365/300 nm light excitation. Benefiting from the diverse thermal response emission behaviors of Eu2+ (530 nm) and Eu3+ (703 nm), Sr1.95+xLi1-xSi1-xAlxO4F:0.05Eu phosphors exhibit temperature sensing performances, with the maximum absolute and relative sensitivity being 0.0294 K-1 at 573 K and 0.83% K-1 at 348 K. More importantly, Sr1.95+xLi1-xSi1-xAlxO4F:0.05Eu phosphors showed excellent stability in humid, acid, and alkali environments, which contributed to applying mixed-valence Eu2+/3+-doped Sr1.95+xLi1-xSi1-xAlxO4F to the fields of multicolor anticounterfeiting and noncontact optical thermometry.

Simultaneous Broadening and Enhancement of Cr3+ Photoluminescence in LiIn2 SbO6 by Chemical Unit Cosubstitution: Night-Vision and Near-Infrared Spectroscopy Detection Applications.

Near-infrared (NIR)-emitting phosphor materials have been extensively developed for optoelectronic and biomedical applications. Although Cr3+ -activated phosphors have been widely reported, it is challenging to achieve ultra-broad and tunable NIR emission. Here, a new ultra-broadband NIR-emitting LiIn2 SbO6 :Cr3+ phosphor with emission peak at 965 nm and a full-width at half maximum of 217 nm is reported. Controllable emission tuning from 965 to 892 nm is achieved by chemical unit cosubstitution of [Zn2+ -Zn2+ ] for [Li+ -In3+ ], which can be ascribed to the upshift of 4 T2g energy level due to the strengthened crystal field. Moreover, the emission is greatly enhanced, and the FWHM reaches 235 nm. The as-prepared luminescent tunable NIR-emitting phosphors have demonstrated the potential in night-vision and NIR spectroscopy techniques. This work proves the feasibility of chemical unit cosubstitution strategy in emission tuning of Cr3+ -doped phosphors, which can stimulate further studies on the emission-tunable NIR-emitting phosphor materials.

Stiffness Could be a Predictor of AJCC Prognostic Stage Groups in Preoperative Invasive Ductal Carcinoma.

OBJECTIVES: This study aimed to evaluate the stiffness of 2-dimensional (2D) shear wave elastography (SWE) in preoperatively predicting the prognostic stage groups of invasive ductal carcinoma (IDC). METHODS: Eighty-six newly diagnosed lesions on 83 patients with IDCs were analyzed. All parameters from conventional ultrasound and stiffness to virtual touch tissue imaging and quantification were collected, and mean shear wave velocity (SWVmean) was calculated. Data on maximum diameter, estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), histologic grading system and Tumor Node Metastasis (TNM) stages were collected. The levels of maximum shear wave velocity (SWVmax), minimum shear wave velocity (SWVmin) and SWVmean were compared. In receiver operating characteristic (ROC) curves analysis, the diagnostic efficacy was found in area under the curve (AUC). Parallel mode was used to improve the predictive value of sensitivity. RESULTS: The median stiffness of SWVmax and SWVmean for IDCs were 9.38 and 6.32 m/s for late stage (stages II, III, IV) and 6.39 m/s and 4.72 m/s for early stage (stage I) of the prognostic stage groups, respectively. The median stiffness values in the late stage were significantly higher than those in the early stage (P = .003, P = .005). The optimal cutoff stiffness of SWVmax and SWVmean were 8.62 and 6.13 m/s, respectively. In ROC curves analysis, the AUC for SWVmax was 0.742, and it showed a better diagnostic value than SWVmean (0.725). In predictive diagnosis, the sensitivity for SWVmax and SWVmean were both 62.50%. The parallel mode improved the prediction power of sensitivity to 68.75%. CONCLUSIONS: Preoperative SWV level may serve as a promising prognostic imaging indicator for breast IDCs.